Validation and comparison of euroqol and short form 6D in chronic prostatitis patients

Value in Health

Volumn 13, Issue 5, 2010, Pages 649-656

  Zhao, Fei Li ^a   Yue, Ming ^b   Yang, Hua ^c   Wang, Tian ^c   Wu, Jiu Hong ^b   Li, Shu Chuen ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b 306 HOSPITAL OF PLA   (China)

^c First People's Hospital of Yunnan Province   (China)

Author keywords

China; chronic prostatitis; EQ 5D; SF 6D; utility; validation study

Indexed keywords

ADULT; ARTICLE; CHINA; CHRONIC PROSTATITIS; CLINICAL DECISION MAKING; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EUROQOL; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SHORT FORM 6D; VALIDATION STUDY;

EID: 77955361736     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00728.x     Document Type: Article

References (33)

1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Intern Med 1993 118 : 622 629.
2. Robinson R. Cost-utility analysis. BMJ 1993 307 : 859 862.
3. Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996 276 : 1339 1341.
4. National Institute for Clinical Excellence. Guide to the methods of health technology appraisal. London, June 2008.
5. Australia Pharmaceutical Benefits Advisory Committee(PBAC). Guidelines for preparing submissions to the PBAC. Canberra, November 2006.
6. Ontario Ministry of Health and Long-term Care. Ontario guidelines for economic analysis of pharmaceutical products. Ontario, August 1994.
7. Liang CZ, Li HJ, Wang ZP, et al. The prevalence of prostatitis-like symptoms in China. J Urol 2009 182 : 558 563.
8. Ku JH, Kim SW, Paick JS. Epidemiologic risk factors for chronic prostatitis. Int J Androl 2005 28 : 317 327.
9. Liang CZ, Li HJ, Wang ZP, et al. Treatment of chronic prostatitis in Chinese men. Asian J Androl 2009 11 : 153 156.
10. McNaughton Collins M. The impact of chronic prostatitis/chronic pelvic pain syndrome on patients. World J Urol 2003 21 : 86 9.
11. Calhoun EA, McNaughton Collins M, Pontari MA, et al. The economic impact of chronic prostatitis. Arch Intern Med 2004 164 : 1231 1236.
12. Ku JH, Kim SW, Paick JS. Quality of life and psychological factors in chronic prostatitis/chronic pelvic pain syndrome. Urology 2005 66 : 693 701.
13. Harrison MJ, Davies LM, Bansback NJ, et al. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol 2008 35 : 592 602.
14. Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003 56 : 317 325.
15. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 1108.
16. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002 21 : 271 292.
17. Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health 2008 11 : 295 303.
18. Schaeffer AJ, Datta NS, Fowler JE, et al. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 2002 60 : 1 4.
19. Litwin MS, McNaughton-Collins M, Fowler FJ Jr., et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999 162 : 369 375.
20. Nickel JC. Special report on prostatitis: state of the art: highlights of the Third Annual International Prostatitis Collaborative Network Meeting October 23-25, 2000, Washington, DC. Rev Urol 2001 3 : 94 8.
21. Liang CZ, Zhang XJ, Hao ZY, et al. An epidemiological study of patients with chronic prostatitis. BJU Int 2004 94 : 568 570.
22. Juniper E, Gordon H, Roman J. How to develop and validate a new health-related quality of life instrument. In : Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials (2nd ed.). Philadelphia, PA : Lippincott-Raven Publishers, 1996.
23. Nickel JC, Downey J, Hunter D, et al. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001 165 : 842 845.
24. Barton GR, Sach TH, Avery AJ, et al. A comparison of the performance of the EQ-5D and SF-6D for individuals aged > or = 45 years. Health Econ 2008 17 : 815 832.
25. Osborne RH, Hawthorne G, Lew EA, et al. Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36. J Clin Epidemiol 2003 56 : 138 147.
26. Fayers PM, Machin D. Quality of Life: the Assessment, Analysis and Interpretation of Patient-Reported Outcomes (2nd ed.). Chichester, West Sussex, UK : John Wiley & Sons, Ltd., 2007.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 310.
28. National Bureau of Statistics in China. China Statistical Yearbook 2008. Available from: http://www.stats.gov.cn/tjsj/ndsj/2008/indexeh.htm [Accessed May 26, 2009 J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004 13 : 873 884.
29. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes 2003 1 : 4.
30. Wenninger K, Heiman JR, Rothman I, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996 155 : 965 968.
31. Wee HL, Machin D, Loke WC, et al. Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value Health 2007 10 : 256 265.
32. Xie F, Li SC, Luo N, et al. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum 2007 57 : 1043 1049.
33. EuroQol Group. Available from: http://www.euroqol.org/eq-5d/eq-5d- versions.html [Accessed June 6, 2009 M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 2001 16 : 656 662.